Renal decline in patients with atrial fibrillation treated with rivaroxaban or warfarin: a population-based cohort study in the United Kingdom
Event: ESC Congress 2021 - The Digital Experience
Topic: Antiplatelet Drugs
Session: Congress committee e-posters choice in pharmacology and pharmacotherapy
